Research and Development

The Research and Development team at Intellia Therapeutics is dedicated to advancing innovative genome editing therapies aimed at treating severe and life-threatening diseases. This multidisciplinary group conducts cutting-edge research, manages clinical trials, and collaborates on product planning and regulatory strategies to ensure the safe and effective development of new gene editing treatments. Their expertise spans pharmacovigilance, biostatistics, assay development, and supply chain management, driving the progression of therapies from concept to clinical application.